These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12814654)

  • 21. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
    Downey AS; Chong CR; Graczyk TK; Sullivan DJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study on the biology of Cryptosporidium sp. from guinea pigs and Cryptosporidium parvum (Apicomplexa).
    Tilley M; Upton SJ; Chrisp CE
    Can J Microbiol; 1991 Dec; 37(12):949-952. PubMed ID: 1806211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of viability and infectivity of Cryptosporidium parvum oocysts stored in potassium dichromate solution and chlorinated tap water.
    Chen F; Huang K; Qin S; Zhao Y; Pan C
    Vet Parasitol; 2007 Nov; 150(1-2):13-7. PubMed ID: 17954011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum.
    Al-Mathal EM; Alsalem AM
    Exp Parasitol; 2012 Jul; 131(3):350-7. PubMed ID: 22580265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hydrogen peroxide and other protease inhibitors on Cryptosporidium parvum excystation and in vitro development.
    Kniel KE; Sumner SS; Pierson MD; Zajac AM; Hackney CR; Fayer R; Lindsay DS
    J Parasitol; 2004 Aug; 90(4):885-8. PubMed ID: 15357093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of decoquinate against Cryptosporidium parvum in cell cultures and neonatal mice.
    Lindsay DS; Woods KM; Upton SJ; Blagburn BL
    Vet Parasitol; 2000 May; 89(4):307-11. PubMed ID: 10799844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
    Surl CG; Kim HC
    J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
    Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
    Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
    Watarai S; Tana ; Koiwa M
    J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin mitigates Cryptosporidium parvum infection through modulation of gut microbiota and innate immune-related genes in immunosuppressed neonatal mice.
    Rahman SU; Zhou K; Zhou S; Sun T; Mi R; Huang Y; Han X; Gong H; Chen Z
    Microb Pathog; 2022 Mar; 164():105424. PubMed ID: 35092833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptosporidium parvum life cycle in suckling mice: a Nomarski interference-contrast study of a human-derived strain.
    Scaglia M; Bruno A; Chichino G; Atzori C; Cevini C; Gatti S
    J Protozool; 1991; 38(6):118S-121S. PubMed ID: 1818130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB/c mice and MDBK cells.
    Chen F; Huang K
    Parasitol Res; 2012 Oct; 111(4):1827-32. PubMed ID: 22782478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calves as a potential reservoir of Cryptosporidium parvum and Giardia sp.
    Bednarska M; Bajer A; Siński E
    Ann Agric Environ Med; 1998; 5(2):135-8. PubMed ID: 9860815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
    Sulkowski MS; Mehta SH; Chaisson RE; Thomas DL; Moore RD
    AIDS; 2004 Nov; 18(17):2277-84. PubMed ID: 15577540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids.
    Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A
    Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats.
    Armson A; Sargent K; MacDonald LM; Finn MP; Thompson RC; Reynoldson JA
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):109-13. PubMed ID: 10536296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.
    Hashim A; Mulcahy G; Bourke B; Clyne M
    Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulinase-like Protease 1 Contributes to Macrogamont Formation in Cryptosporidium parvum.
    Xu R; Feng Y; Xiao L; Sibley LD
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.
    Carr A; Marriott D; Field A; Vasak E; Cooper DA
    Lancet; 1998 Jan; 351(9098):256-61. PubMed ID: 9457096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.